Dr Michael J Arruza Elias, MD in Caguas, PR - Medicare Otolaryngology

Dr Michael J Arruza Elias, MD is a medicare enrolled "Otolaryngology" physician in Caguas, Puerto Rico. He went to University Of Puerto Rico School Of Medicine and graduated in 1992 and has 32 years of diverse experience with area of expertise as Otolaryngology. His current practice location is Segundo Nivel Oficina #203, Las Catalinas Cinemas, Caguas, Puerto Rico. You can reach out to his office (for appointments etc.) via phone at (787) 286-1225.

Dr Michael J Arruza Elias is licensed to practice in Puerto Rico (license number 12112) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1861473837.

Contact Information

	Dr Michael J Arruza Elias, MD
	Segundo Nivel Oficina #203, Las Catalinas Cinemas, Caguas, PR 00725
	(787) 286-1225
	(787) 286-1221

Physician's Profile

Full Name	Dr Michael J Arruza Elias
Gender	Male
Speciality	Otolaryngology
Experience	32 Years
Location	Segundo Nivel Oficina #203, Caguas, Puerto Rico
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Michael J Arruza Elias attended and graduated from University Of Puerto Rico School Of Medicine in 1992

NPI Data:

NPI Number: 1861473837
Provider Enumeration Date: 11/08/2005
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 9234318544
Enrollment ID: I20110119000380

Medical Identifiers

Medical identifiers for Dr Michael J Arruza Elias such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1861473837	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	12112 (Puerto Rico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Michael J Arruza Elias is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Michael J Arruza Elias, MD Po Box 486, Caguas, PR 00726-0486 Ph: (787) 286-1225	Dr Michael J Arruza Elias, MD Segundo Nivel Oficina #203, Las Catalinas Cinemas, Caguas, PR 00725 Ph: (787) 286-1225

News Archive

'Ultra-bad' cholesterol increases risk of heart disease in people with type 2 diabetes

Scientists from the University of Warwick have discovered why a newly found form of cholesterol seems to be 'ultra-bad', leading to increased risk of heart disease. The discovery could lead to new treatments to prevent heart disease particularly in people with type 2 diabetes and the elderly.

AIDS campaigners call on British and French governments to develop a common strategy to fight HIV/AIDS

In a report published today, the Global AIDS Alliance, a grassroots campaign, gives its wholehearted backing to Gordon Brown's proposed International Finance Facility (the IFF) and calls on the French government to work with Brown to capitalise the Facility with revenues obtained from the French proposal for an airline tax.

Beta-blockers not associated with reduced risk of heart attacks, death and strokes

A new study conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found using beta-blockers, the standard of care for patients with coronary artery disease (CAD), was not associated with a lower risk of heart attacks, death and strokes in patients suffering from CAD and those with risk factors for the disease, including those with a history of heart attack.

RTI, Medtronic take several steps to continuously improve their relationship

RTI Biologics Inc., a leading processor of orthopedic and other biologic implants, in response to inquiries regarding Medtronic's announced acquisition of Osteotech stated today that the relationship between Medtronic and RTI Biologics continues to be strong, with no changes near-term.

Dr Michael J Arruza Elias, MD - Medicare Otolaryngology in Caguas, PR